ES2162347T3 - Deteccion de igm especifica para un antigeno. - Google Patents

Deteccion de igm especifica para un antigeno.

Info

Publication number
ES2162347T3
ES2162347T3 ES97953700T ES97953700T ES2162347T3 ES 2162347 T3 ES2162347 T3 ES 2162347T3 ES 97953700 T ES97953700 T ES 97953700T ES 97953700 T ES97953700 T ES 97953700T ES 2162347 T3 ES2162347 T3 ES 2162347T3
Authority
ES
Spain
Prior art keywords
antigen
class
monomero
antigens
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97953700T
Other languages
English (en)
Inventor
Elke Faatz
Urban Schmitt
Beatus Ofenloch-Hahnle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Application granted granted Critical
Publication of ES2162347T3 publication Critical patent/ES2162347T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCEDIMIENTO PARA DETERMINAR ANTICUERPOS ESPECIFICOS DE ANTIGENOS DE LA INMUNOGLOBULINA CLASE M, EN PRESENCIA DE INMUNOGLOBULINAS DE CLASE G Y/O DEL FACTOR REUMATOIDE, EN FLUIDOS CORPORALES, POR INCUBACION CON AL MENOS DOS RECEPTORES DIFERENTES, R 1 Y R 2 , Y RECEPTO RES OPTATIVAMENTE ADICIONALES, CARACTERIZADO PORQUE UNO DE LOS ELEMENTOS DE FIJACION EN FORMA DE POLIMERO ES UN CONSTITUYENTE SUSTANCIAL DE R 2 , Y LOS EFECTOS PERTURBADORES DE LOS ANTICUERPOS IGM CON LA MISMA ESPECIFICIDAD AL ANTIGENO SE SUPRIMEN POR UNION DE LOS ELEMENTOS COLABORADORES EN FORMA DE MONOMERO. LA INVENCION SE REFIERE IGUALMENTE A UN REACTIVO PARA DETERMINAR UN ANTICUERPO ESPECIFICO DE UN ANTIGENO DE INMUNOGLOBULINA CLASE M, Y EL USO DE ELEMENTOS COLABORADORES DE UNION EN FORMA DE MONOMERO, PARA SUPRIMIR LOS EFECTOS PERTURBADORES DE LOS ANTICUERPOS IGM EN LA DETERMINACION DE ANTICUERPOS IGM ESPECIFICOS DE ANTIGENOS.
ES97953700T 1996-11-29 1997-11-26 Deteccion de igm especifica para un antigeno. Expired - Lifetime ES2162347T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19649389A DE19649389A1 (de) 1996-11-29 1996-11-29 Antigenspezifischer IgM-Nachweis

Publications (1)

Publication Number Publication Date
ES2162347T3 true ES2162347T3 (es) 2001-12-16

Family

ID=7813066

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97953700T Expired - Lifetime ES2162347T3 (es) 1996-11-29 1997-11-26 Deteccion de igm especifica para un antigeno.

Country Status (18)

Country Link
US (1) US6489129B1 (es)
EP (1) EP0944832B1 (es)
JP (1) JP3958797B2 (es)
KR (1) KR20000057315A (es)
CN (1) CN1245560A (es)
AR (1) AR009638A1 (es)
AT (1) ATE204082T1 (es)
AU (1) AU720123B2 (es)
BR (1) BR9714365A (es)
CA (1) CA2272302A1 (es)
DE (2) DE19649389A1 (es)
ES (1) ES2162347T3 (es)
IL (1) IL130112A0 (es)
NO (1) NO992579L (es)
NZ (1) NZ335754A (es)
TW (1) TW434405B (es)
WO (1) WO1998023955A2 (es)
ZA (1) ZA9710726B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10009503A1 (de) * 2000-02-29 2001-08-30 Roche Diagnostics Gmbh Verfahren zur Immobilisierung von Konjugaten in diagnostischen Tests
WO2002090961A2 (en) * 2001-05-03 2002-11-14 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US7262019B2 (en) * 2001-05-03 2007-08-28 Immunetics, Inc. System and methods for detection of Bacillus anthracis related analytes in biological fluids
US7387890B2 (en) 2004-12-16 2008-06-17 Chembio Diagnostic Systems, Inc. Immunoassay devices and use thereof
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
ES2368624T3 (es) 2007-04-20 2011-11-18 F. Hoffmann-La Roche Ag Detección de infecciones primarias por patógenos.
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
ES2625406T3 (es) 2010-03-25 2017-07-19 Oregon Health & Science University Glicoproteínas de CMV y vectores recombinantes
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
SI2691530T1 (en) 2011-06-10 2018-08-31 Oregon Health & Science University CMV glycoproteins and recombinant vectors
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
CN102507932A (zh) * 2011-12-02 2012-06-20 无锡博慧斯生物医药科技有限公司 一种IgM抗体检测试纸条
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
AU2015241521B2 (en) 2014-04-02 2019-12-19 Chembio Diagnostic Systems, Inc. Immunoassay utilizing trapping conjugate
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3176580A1 (en) * 2015-12-01 2017-06-07 Roche Diagnostics GmbH Method for reduction of interferences in immunoassays
CN105759059A (zh) * 2016-04-27 2016-07-13 丹娜（天津）生物科技有限公司 一种检测EV71病毒IgM抗体的免疫检测试剂盒及其制备方法
CN105974111B (zh) * 2016-07-20 2019-07-09 国家纳米科学中心 一种类风湿因子(IgM型)及其他抗原特异性IgM抗体联合检测的方法
CN107656057A (zh) * 2017-09-06 2018-02-02 中国农业科学院兰州兽医研究所 一种用于检测布鲁氏杆菌病IgM抗体的ELISA试剂盒及其应用
US11959917B2 (en) 2018-09-18 2024-04-16 Siemens Healthcare Diagnostics Inc. Methods and reagents for Zika virus immunoassays
CN113495141A (zh) * 2020-03-20 2021-10-12 迈克生物股份有限公司 2019新型冠状病毒IgM抗体检测试剂盒

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80129A0 (en) * 1986-09-23 1986-12-31 Savyon Diagnostics Ltd Method for the determination of igm and iga immunoglobulins and reagents therefor
DE3705686C2 (de) * 1987-02-23 1995-11-30 Boehringer Mannheim Gmbh Verfahren zur Bestimmung von Antikörpern
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
DE3717401A1 (de) * 1987-05-23 1988-12-08 Behringwerke Ag Einschritt-immuntest zur bestimmung von antigen-spezifischen antikoerpern aus einer der immunglobulin-klassen a, m, d oder e und dazu geeignetes mittel
NZ291153A (en) 1994-07-25 1999-01-28 Boehringer Mannheim Gmbh Determination of a specific antibody using multiple antigens containing several epitope regions which react with the antibody
AU684992B2 (en) * 1994-07-25 1998-01-08 Boehringer Mannheim Gmbh Hapten-marked peptides
DE4439452A1 (de) * 1994-11-04 1996-05-09 Boehringer Mannheim Gmbh Antikörperklassenspezifisches Entstörungsreagenz

Also Published As

Publication number Publication date
JP3958797B2 (ja) 2007-08-15
JP2001506749A (ja) 2001-05-22
DE59704261D1 (de) 2001-09-13
KR20000057315A (ko) 2000-09-15
WO1998023955A2 (de) 1998-06-04
DE19649389A1 (de) 1998-06-04
WO1998023955A3 (de) 1998-07-23
NO992579L (no) 1999-07-28
NZ335754A (en) 2001-05-25
BR9714365A (pt) 2000-03-21
EP0944832A2 (de) 1999-09-29
ZA9710726B (en) 1999-05-28
AU5751398A (en) 1998-06-22
IL130112A0 (en) 2000-06-01
EP0944832B1 (de) 2001-08-08
ATE204082T1 (de) 2001-08-15
CA2272302A1 (en) 1998-06-04
AU720123B2 (en) 2000-05-25
CN1245560A (zh) 2000-02-23
US6489129B1 (en) 2002-12-03
NO992579D0 (no) 1999-05-28
AR009638A1 (es) 2000-04-26
TW434405B (en) 2001-05-16

Similar Documents

Publication Publication Date Title
ES2162347T3 (es) Deteccion de igm especifica para un antigeno.
SE7602834L (sv) Diagnotiskt reagenssystem
BR9714366A (pt) Detecção de igc especìfico de antìgeno
CY1107537T1 (el) Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος
FI970301A (fi) Spesifisen immunoglobuliinin määrittäminen käyttäen useampaa antigeenia
ATE284900T1 (de) Spezifische antikörper für dendritische zellen
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
ATE37095T1 (de) Fluoreszenz-untersuchungsverfahren zur bluttypenbestimmung.
ES2074062T3 (es) Inmunoensayo para antigenos hiv-1 que utilizan fragmentos de f(ab')2 como sonda.
ES2093194T3 (es) Inmunoensayo para detectar streptococcus del grupo b.
ES2138102T3 (es) Procedimiento para la deteccion de antigeno urinario asociado a tumores.
DK196282A (da) Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener
ES2070488T3 (es) Procedimiento para la deteccion de enfermedades malignas.
PT902286E (pt) Imunoensaio utilizando duas incubacoes com antigenios marcados
SE8004542L (sv) Diagnostiskt test
BR0016458A (pt) Reagentes, métodos e kits para detectar proteìnas de bacillus thuringiensis
FR2778744B1 (fr) Dosage immunologique de la chromogranine a humaine (cga) anticorps, reactifs et trousses utilisables pour ce dosage
BR9903250A (pt) Antìgenos e imunoanálises para diagnóstico da doença de chagas.
EP0245052A3 (en) Detection of inflammation and novel antibodies therefor
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
ES2061881T3 (es) Procedimiento para la determinacion de anticuerpos especificos de la clase de un antigeno asi como un reactivo apropiado para ello.
GR920100123A (el) Αντιδραστήριο πολυχρωματικής κηλίδωσης και μέ?οδος ανάλυσης.
ES2084581T3 (es) Inmunoensayos que utilizan antigenos producidos en organismos hetereologicos.
ATE114052T1 (de) Immunoassay zur bestimmung der bindungsspezifität eines monoklonalen antikörpers.
ES2019573A4 (es) Inmunoensayo para la deteccion de (alfa)-haloacetamidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 944832

Country of ref document: ES